In Re: K-Dur Antitrust Litigation

On 16 July 2012, a U.S. appeals court issued a decision holding that pharmaceutical patent settlements that restrict generic entry and contain a payment to the generic company are presumptively…

Reverse payments settlements between patent holders and would-be generic competitors in the pharmaceutical industry should be reviewed under a "quick look" rule of reason analysis based on the…